Cargando…
Elevated TAB182 enhances the radioresistance of esophageal squamous cell carcinoma through G2‐M checkpoint modulation
BACKGROUND: Radiotherapy is one of the main strategies for the treatment of esophageal squamous cell carcinoma (ESCC). However, treatment failure often occurs due to the emergence of radioresistance. In this study, we report a key regulator of radiation sensitivity, termed TAB182 that may become an...
Autores principales: | Cao, Yuandong, Gao, Aidi, Li, Xiaoqing, Min, Han, He, Chao, Sun, Xinchen, Ding, Wei‐Qun, Zhou, Jundong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8085956/ https://www.ncbi.nlm.nih.gov/pubmed/33787085 http://dx.doi.org/10.1002/cam4.3879 |
Ejemplares similares
-
TAB182 aggravates progression of esophageal squamous cell carcinoma by enhancing β-catenin nuclear translocation through FHL2 dependent manner
por: Gao, Aidi, et al.
Publicado: (2022) -
Correction: TAB182 aggravates progression of esophageal squamous cell carcinoma by enhancing β-catenin nuclear translocation through FHL2 dependent manner
por: Gao, Aidi, et al.
Publicado: (2023) -
Polymerase iota (POLI) confers radioresistance of esophageal squamous cell carcinoma by regulating RAD51 stability and facilitating homologous recombination
por: Li, Xiaoqing, et al.
Publicado: (2023) -
DNA Polymerase Iota Promotes Esophageal Squamous Cell Carcinoma Proliferation Through Erk-OGT-Induced G6PD Overactivation
por: Su, Zhenzi, et al.
Publicado: (2021) -
RAD18 confers radioresistance of esophagus squamous cell carcinoma through regulating p‐DNA‐PKcs
por: Li, Xiaoqing, et al.
Publicado: (2022)